KRR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.897400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.619600E-01
Normal-vs-Stage2
7.328600E-01
Normal-vs-Stage3
1.013770E-01
Normal-vs-Stage4
5.883800E-01
Stage1-vs-Stage2
9.927400E-01
Stage1-vs-Stage3
3.227600E-02
Stage1-vs-Stage4
2.098200E-01
Stage2-vs-Stage3
1.479350E-01
Stage2-vs-Stage4
2.406600E-01
Stage3-vs-Stage4
3.326000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.222000E-01
Normal-vs-AfricanAmerican
9.343400E-01
Normal-vs-Asian
1.198600E-01
Caucasian-vs-AfricanAmerican
7.322000E-01
Caucasian-vs-Asian
4.562300E-02
AfricanAmerican-vs-Asian
1.073170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.381200E-01
Normal-vs-Female
6.390000E-01
Male-vs-Female
7.687600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.913000E-01
Normal-vs-Age(41-60Yrs)
8.999400E-01
Normal-vs-Age(61-80Yrs)
4.825600E-01
Normal-vs-Age(81-100Yrs)
5.382000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.936100E-03
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.543600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.722600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.086100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.616830E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.575200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.557600E-01
Normal-vs-Daily Drinker
4.126600E-01
Normal-vs-Weekly Drinker
4.105200E-01
Normal-vs-Occasional Drinker
8.102000E-01
Normal-vs-Social Drinker
6.925400E-01
Non Drinker-vs-Daily Drinker
9.593200E-01
Non Drinker-vs-Weekly Drinker
9.141000E-01
Non Drinker-vs-Occasional Drinker
5.434200E-02
Non Drinker-vs-Social Drinker
2.727000E-01
Daily Drinker-vs-Weekly Drinker
9.042400E-01
Daily Drinker-vs-Occasional Drinker
6.778200E-02
Daily Drinker-vs-Social Drinker
4.106400E-01
Weekly Drinker-vs-Occasional Drinker
1.019410E-01
Weekly Drinker-vs-Social Drinker
3.998800E-01
Occasional Drinker-vs-Social Drinker
3.037400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.600780E-01
Normal-vs-Grade 2
7.143800E-02
Normal-vs-Grade 3
4.432400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.197800E-01
Grade 1-vs-Grade 3
9.643800E-02
Grade 1-vs-Grade 4
1.600780E-01
Grade 2-vs-Grade 3
4.912400E-01
Grade 2-vs-Grade 4
7.143800E-02
Grade 3-vs-Grade 4
4.432400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.538600E-01
Normal-vs-NonDiabetic
5.434800E-01
Diabetic-vs-NonDiabetic
7.426800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.099800E-01
Normal-vs-NoPancreatitis
5.559000E-01
Pancreatitis-vs-NoPancreatitis
7.792200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.482600E-01
Normal-vs-N1
7.763400E-01
N0-vs-N1
3.159600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.540000E-01
Normal-vs-TP53-NonMutant
8.695600E-01
TP53-Mutant-vs-TP53-NonMutant
2.406200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
